Cerebras Systems surges 18% over two days as multiple investment banks raise price targets
0xBroomberg
AI chip maker Cerebras (CBRS.US) rallied 18% over two trading days after multiple banks raised price targets; the stock had fallen over 25% on weak margin guidance, and whether the bounce holds depends on upcoming quarters.
Where did this bounce come from?
Cerebras surged nearly 10% intraday Monday, bringing its two-day gain to 18%.
The stock had dropped over 25% after its first-ever earnings report guided Q2 gross margins to just 36%–38%, briefly falling below its $185 IPO price.
This means → the rally is a recovery from a deep selloff, not a breakout — the starting point was a margin-driven panic.
Why are banks turning bullish together?
UBS raised its target from $300 to $320, maintaining a buy rating.
Wedbush lifted its target to $280, maintaining an outperform rating.
Morgan Stanley noted the company holds a large signed-order backlog and 750 MW of committed capacity agreements — a measure of reserved data-center power that signals heavy AI inference deployment ahead.
In plain terms = all three banks share the same logic: the order book is thick, capacity is locked in, and a near-term margin dip does not break the long-term demand story.
How do the fundamentals actually look?
Q1 core revenue hit $193 million, up 92% year-over-year, beating consensus.
The company signed a multi-year deal with OpenAI worth over $20 billion.
It also reached a data-center deployment agreement with Amazon Web Services (AWS).
This means → both the revenue line and the customer pipeline are accelerating. The question is not "is anyone buying?" — it is "how much profit per sale?"
What is the core tension behind this rally?
Demand signals are strong: Q1 revenue grew fast, and large orders keep landing.
But Q2 gross-margin guidance of just 36%–38% sits well below what the market expects from an AI chip company — and that pressure has not gone away.
In plain terms = the situation is "the product sells, but it doesn't earn enough yet." If margins improve in coming quarters, the bounce thesis holds. If they stay weak, the stock faces renewed pressure.
Content is for reference only, not financial advice.